The analysis of the impact of metformin on LongCOVID was published in Lancet Infectious Diseases, showing that the drug metformin lowered one’s risk of developing LongCOVID by 41.3 ...
THURSDAY, Sept. 19, 2024 (HealthDay News) -- One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for LongCOVID. LongCOVID can present ...
A clinical trial in 2023 showed that treatment with metformin, commonly used to help control blood sugar, reduced the risk of longCOVID by as much as 40% in nearly 1,300 U.S. adults with ...
There's new data supporting the notion that the widely used diabetes drug metformin can cut users' odds for LongCOVID The drug also reduced the odds that a person with type 2 diabetes would die ...
Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing longCovid or dying after a Covid-19 infection than people with diabetes who take ...
Results that may be inaccessible to you are currently showing.